These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32410255)

  • 21. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.
    Deng HY; Luo J; Li SX; Li G; Alai G; Wang Y; Liu LX; Lin YD
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30496378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
    Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of left tracheobronchial lymph node dissection in thoracic esophageal squamous cell carcinoma.
    Xu L; Wei XF; Chen XK; Qi S; Yu YK; Liu Q; Xie HN; Yang YF; Zhang RX; Li Y
    J Thorac Cardiovasc Surg; 2022 Oct; 164(4):1210-1219.e3. PubMed ID: 35400494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomy.
    Koterazawa Y; Goto H; Saiga H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Oshikiri T; Kakeji Y
    Surg Endosc; 2024 Jul; 38(7):3625-3635. PubMed ID: 38767690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
    Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
    Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
    Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
    Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic ligation of the thoracic duct in the prevention of chylothorax after esophagectomy.
    Jínek T; Adamčík L; Duda M; Buzrla P; Škrovina M
    Rozhl Chir; 2018; 97(7):328-334. PubMed ID: 30442014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thoracoscopic radical esophagectomy combined with left inferior pulmonary ligament lymphadenectomy for esophageal carcinoma via the right thoracic approach: A single-center retrospective study of 30 cases.
    Huang S; Yang T; Wang W; Huang G; Chen B; Chen P; Ke D; Huang W; Xie J
    Medicine (Baltimore); 2021 Jun; 100(23):e26302. PubMed ID: 34115038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer.
    Liu Z; Du M; Liang Y; Ju S; Li X; Gao Y
    Surg Today; 2020 Aug; 50(8):881-888. PubMed ID: 31980933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma.
    Ye K; Xu JH; Sun YF; Lin JA; Zheng ZG
    Genet Mol Res; 2014 Aug; 13(3):6411-9. PubMed ID: 25158259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
    Wu LL; Zhong JD; Zhu JL; Kang L; Huang YY; Lin P; Long H; Zhang LJ; Ma QL; Qiu LH; Ma GW
    BMC Cancer; 2022 Jan; 22(1):118. PubMed ID: 35090428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
    Yamashita K; Makino T; Yamasaki M; Tanaka K; Hara T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
    Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
    Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer.
    Cagol M; Ruol A; Castoro C; Alfieri R; Michieletto S; Ancona E
    World J Surg; 2009 Aug; 33(8):1684-6. PubMed ID: 19533219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.